Negative Regulation of Pulmonary Th17 Responses by C3a Anaphylatoxin during Allergic Inflammation in Mice

PLoS ONE

Volumn 7, Issue 12, 2012, Pages

  Lim, Hoyong ^a   Kim, Young Uk ^a,b   Drouin, Scott M ^a,b   Mueller Ortiz, Stacey ^a   Yun, Kyoungah ^a,c   Morschl, Eva ^a   Wetsel, Rick A ^a,b   Chung, Yeonseok ^a,b  

^a UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF TEXAS   (United States)

^c Daejon Health Sciences College   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; COMPLEMENT; COMPLEMENT RECEPTOR; CYTOKINE; INTERLEUKIN 17; PROTEIN C3A ANAPHYLATOXIN; PROTEIN C3A RECEPTOR; TRANSCRIPTION FACTOR FOXP3; UNCLASSIFIED DRUG;

ADOPTIVE TRANSFER; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN SPECIFICITY; ARTICLE; ASTHMA; CD4+ T LYMPHOCYTE; CONTROLLED STUDY; CYTOKINE PRODUCTION; HEMATOPOIETIC CELL; IMMUNOREGULATION; LUNG LAVAGE; LYMPH NODE; LYMPHOCYTE SUBPOPULATION; MOUSE; NEUTROPHIL COUNT; NONHUMAN; RECIPIENT; REGULATORY T LYMPHOCYTE; SIGNAL TRANSDUCTION; T CELL DEPLETION; TH17 CELL; WILD TYPE;

ALLERGENS; ANAPHYLATOXINS; ANIMALS; COMPLEMENT C3A; DISEASE MODELS, ANIMAL; FORKHEAD TRANSCRIPTION FACTORS; HYPERSENSITIVITY; INTERLEUKIN-17; MICE; MICE, KNOCKOUT; NEUTROPHIL INFILTRATION; NEUTROPHILS; PNEUMONIA; RECEPTORS, COMPLEMENT; SIGNAL TRANSDUCTION; T-LYMPHOCYTES, REGULATORY; TH17 CELLS;

ANIMALIA; MUS;

EID: 84871415830     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0052666     Document Type: Article

References (83)

1. Lloyd CM, Hessel EM, (2010) Functions of T cells in asthma: more than just T(H)2 cells. Nat Rev Immunol 10: 838-848.
2. Grunig G, Warnock M, Wakil AE, Venkayya R, Brombacher F, et al. (1998) Requirement for IL-13 independently of IL-4 in experimental asthma. Science 282: 2261-2263.
3. Corry DB, Kheradmand F, (2002) Biology and therapeutic potential of the interleukin-4/interleukin-13 signaling pathway in asthma. Am J Respir Med 1: 185-193.
4. Alcorn JF, Crowe CR, Kolls JK, (2010) TH17 cells in asthma and COPD. Annu Rev Physiol 72: 495-516.
5. Lajoie S, Lewkowich IP, Suzuki Y, Clark JR, Sproles AA, et al. (2010) Complement-mediated regulation of the IL-17A axis is a central genetic determinant of the severity of experimental allergic asthma. Nat Immunol 11: 928-935.
6. Souwer Y, Szegedi K, Kapsenberg ML, de Jong EC, (2010) IL-17 and IL-22 in atopic allergic disease. Curr Opin Immunol 22: 821-826.
7. Ivanov, II, McKenzie BS, Zhou L, Tadokoro CE, Lepelley A, et al. (2006) The orphan nuclear receptor RORgammat directs the differentiation program of proinflammatory IL-17+ T helper cells. Cell 126: 1121-1133.
8. Yang XO, Pappu BP, Nurieva R, Akimzhanov A, Kang HS, et al. (2008) T helper 17 lineage differentiation is programmed by orphan nuclear receptors ROR alpha and ROR gamma. Immunity 28: 29-39.
9. Bettelli E, Carrier Y, Gao W, Korn T, Strom TB, et al. (2006) Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells. Nature 441: 235-238.
10. Korn T, Bettelli E, Oukka M, Kuchroo VK, (2009) IL-17 and Th17 Cells. Annu Rev Immunol 27: 485-517.
11. McGeachy MJ, Chen Y, Tato CM, Laurence A, Joyce-Shaikh B, et al. (2009) The interleukin 23 receptor is essential for the terminal differentiation of interleukin 17-producing effector T helper cells in vivo. Nat Immunol 10: 314-324.
12. Chung Y, Chang SH, Martinez GJ, Yang XO, Nurieva R, et al. (2009) Critical regulation of early Th17 cell differentiation by interleukin-1 signaling. Immunity 30: 576-587.
13. Wilson NJ, Boniface K, Chan JR, McKenzie BS, Blumenschein WM, et al. (2007) Development, cytokine profile and function of human interleukin 17-producing helper T cells. Nat Immunol 8: 950-957.
14. Langrish CL, Chen Y, Blumenschein WM, Mattson J, Basham B, et al. (2005) IL-23 drives a pathogenic T cell population that induces autoimmune inflammation. J Exp Med 201: 233-240.
15. Hirota K, Yoshitomi H, Hashimoto M, Maeda S, Teradaira S, et al. (2007) Preferential recruitment of CCR6-expressing Th17 cells to inflamed joints via CCL20 in rheumatoid arthritis and its animal model. J Exp Med 204: 2803-2812.
16. Molet S, Hamid Q, Davoine F, Nutku E, Taha R, et al. (2001) IL-17 is increased in asthmatic airways and induces human bronchial fibroblasts to produce cytokines. J Allergy Clin Immunol 108: 430-438.
17. Krueger GG, Langley RG, Leonardi C, Yeilding N, Guzzo C, et al. (2007) A human interleukin-12/23 monoclonal antibody for the treatment of psoriasis. N Engl J Med 356: 580-592.
18. Duerr RH, Taylor KD, Brant SR, Rioux JD, Silverberg MS, et al. (2006) A genome-wide association study identifies IL23R as an inflammatory bowel disease gene. Science 314: 1461-1463.
19. Ishizu T, Osoegawa M, Mei FJ, Kikuchi H, Tanaka M, et al. (2005) Intrathecal activation of the IL-17/IL-8 axis in opticospinal multiple sclerosis. Brain 128: 988-1002.
20. Leonardi C, Matheson R, Zachariae C, Cameron G, Li L, et al. (2012) Anti-interleukin-17 monoclonal antibody ixekizumab in chronic plaque psoriasis. N Engl J Med 366: 1190-1199.
21. Genovese MC, Van den Bosch F, Roberson SA, Bojin S, Biagini IM, et al. (2010) LY2439821, a humanized anti-interleukin-17 monoclonal antibody, in the treatment of patients with rheumatoid arthritis: A phase I randomized, double-blind, placebo-controlled, proof-of-concept study. Arthritis Rheum 62: 929-939.
22. Hueber W, Patel DD, Dryja T, Wright AM, Koroleva I, et al. (2010) Effects of AIN457, a fully human antibody to interleukin-17A, on psoriasis, rheumatoid arthritis, and uveitis. Sci Transl Med 2: 52ra72.
23. Finkelman FD, Hogan SP, Hershey GK, Rothenberg ME, Wills-Karp M, (2010) Importance of cytokines in murine allergic airway disease and human asthma. J Immunol 184: 1663-1674.
24. Bullens DM, Truyen E, Coteur L, Dilissen E, Hellings PW, et al. (2006) IL-17 mRNA in sputum of asthmatic patients: linking T cell driven inflammation and granulocytic influx? Respir Res 7: 135.
25. Mucida D, Salek-Ardakani S, (2009) Regulation of TH17 cells in the mucosal surfaces. J Allergy Clin Immunol 123: 997-1003.
26. Hamid Q, Tulic M, (2009) Immunobiology of asthma. Annu Rev Physiol 71: 489-507.
27. Larche M, (2006) Immunoregulation by targeting T cells in the treatment of allergy and asthma. Curr Opin Immunol 18: 745-750.
28. Douwes J, Gibson P, Pekkanen J, Pearce N, (2002) Non-eosinophilic asthma: importance and possible mechanisms. Thorax 57: 643-648.
29. Louis R, Lau LC, Bron AO, Roldaan AC, Radermecker M, et al. (2000) The relationship between airways inflammation and asthma severity. Am J Respir Crit Care Med 161: 9-16.
30. Woodruff PG, Khashayar R, Lazarus SC, Janson S, Avila P, et al. (2001) Relationship between airway inflammation, hyperresponsiveness, and obstruction in asthma. J Allergy Clin Immunol 108: 753-758.
31. Kudo M, Melton AC, Chen C, Engler MB, Huang KE, et al. (2012) IL-17A produced by alphabeta T cells drives airway hyper-responsiveness in mice and enhances mouse and human airway smooth muscle contraction. Nat Med 18: 547-554.
32. McKinley L, Alcorn JF, Peterson A, Dupont RB, Kapadia S, et al. (2008) TH17 cells mediate steroid-resistant airway inflammation and airway hyperresponsiveness in mice. J Immunol 181: 4089-4097.
33. Hellings PW, Kasran A, Liu Z, Vandekerckhove P, Wuyts A, et al. (2003) Interleukin-17 orchestrates the granulocyte influx into airways after allergen inhalation in a mouse model of allergic asthma. Am J Respir Cell Mol Biol 28: 42-50.
34. Laan M, Cui ZH, Hoshino H, Lotvall J, Sjostrand M, et al. (1999) Neutrophil recruitment by human IL-17 via C-X-C chemokine release in the airways. J Immunol 162: 2347-2352.
35. Wu Q, Martin RJ, Rino JG, Breed R, Torres RM, et al. (2007) IL-23-dependent IL-17 production is essential in neutrophil recruitment and activity in mouse lung defense against respiratory Mycoplasma pneumoniae infection. Microbes Infect 9: 78-86.
36. Schnyder-Candrian S, Togbe D, Couillin I, Mercier I, Brombacher F, et al. (2006) Interleukin-17 is a negative regulator of established allergic asthma. J Exp Med 203: 2715-2725.
37. Murdoch JR, Lloyd CM, (2010) Resolution of allergic airway inflammation and airway hyperreactivity is mediated by IL-17-producing {gamma}{delta}T cells. Am J Respir Crit Care Med 182: 464-476.
38. Walport MJ, (2001) Complement. First of two parts. N Engl J Med 344: 1058-1066.
39. Walport MJ, (2001) Complement. Second of two parts. N Engl J Med 344: 1140-1144.
40. Ricklin D, Hajishengallis G, Yang K, Lambris JD, (2010) Complement: a key system for immune surveillance and homeostasis. Nat Immunol 11: 785-797.
41. Kohl J, (2006) The role of complement in danger sensing and transmission. Immunol Res 34: 157-176.
42. Sarma VJ, Huber-Lang M, Ward PA, (2006) Complement in lung disease. Autoimmunity 39: 387-394.
43. Drouin SM, Kildsgaard J, Haviland J, Zabner J, Jia HP, et al. (2001) Expression of the complement anaphylatoxin C3a and C5a receptors on bronchial epithelial and smooth muscle cells in models of sepsis and asthma. J Immunol 166: 2025-2032.
44. Monsinjon T, Gasque P, Chan P, Ischenko A, Brady JJ, et al. (2003) Regulation by complement C3a and C5a anaphylatoxins of cytokine production in human umbilical vein endothelial cells. FASEB J 17: 1003-1014.
45. Reca R, Mastellos D, Majka M, Marquez L, Ratajczak J, et al. (2003) Functional receptor for C3a anaphylatoxin is expressed by normal hematopoietic stem/progenitor cells, and C3a enhances their homing-related responses to SDF-1. Blood 101: 3784-3793.
46. Werfel T, Kirchhoff K, Wittmann M, Begemann G, Kapp A, et al. (2000) Activated human T lymphocytes express a functional C3a receptor. J Immunol 165: 6599-6605.
47. Martin U, Bock D, Arseniev L, Tornetta MA, Ames RS, et al. (1997) The human C3a receptor is expressed on neutrophils and monocytes, but not on B or T lymphocytes. J Exp Med 186: 199-207.
48. Gutzmer R, Lisewski M, Zwirner J, Mommert S, Diesel C, et al. (2004) Human monocyte-derived dendritic cells are chemoattracted to C3a after up-regulation of the C3a receptor with interferons. Immunology 111: 435-443.
49. Krug N, Tschernig T, Erpenbeck VJ, Hohlfeld JM, Kohl J, (2001) Complement factors C3a and C5a are increased in bronchoalveolar lavage fluid after segmental allergen provocation in subjects with asthma. Am J Respir Crit Care Med 164: 1841-1843.
50. Humbles AA, Lu B, Nilsson CA, Lilly C, Israel E, et al. (2000) A role for the C3a anaphylatoxin receptor in the effector phase of asthma. Nature 406: 998-1001.
51. van de Graaf EA, Jansen HM, Bakker MM, Alberts C, Eeftinck Schattenkerk JK, et al. (1992) ELISA of complement C3a in bronchoalveolar lavage fluid. J Immunol Methods 147: 241-250.
52. Drouin SM, Corry DB, Hollman TJ, Kildsgaard J, Wetsel RA, (2002) Absence of the complement anaphylatoxin C3a receptor suppresses Th2 effector functions in a murine model of pulmonary allergy. J Immunol 169: 5926-5933.
53. Baelder R, Fuchs B, Bautsch W, Zwirner J, Kohl J, et al. (2005) Pharmacological targeting of anaphylatoxin receptors during the effector phase of allergic asthma suppresses airway hyperresponsiveness and airway inflammation. J Immunol 174: 783-789.
54. Mizutani N, Nabe T, Yoshino S, (2009) Complement C3a regulates late asthmatic response and airway hyperresponsiveness in mice. J Immunol 183: 4039-4046.
55. Lo Re S, Dumoutier L, Couillin I, Van Vyve C, Yakoub Y, et al. (2010) IL-17A-producing gammadelta T and Th17 lymphocytes mediate lung inflammation but not fibrosis in experimental silicosis. J Immunol 184: 6367-6377.
56. Yu S, Zhao J, Cantorna MT, (2011) Invariant NKT cell defects in vitamin D receptor knockout mice prevents experimental lung inflammation. J Immunol 187: 4907-4912.
57. Eustace A, Smyth LJ, Mitchell L, Williamson K, Plumb J, et al. (2011) Identification of cells expressing IL-17A and IL-17F in the lungs of patients with COPD. Chest 139: 1089-1100.
58. Kheradmand F, Kiss A, Xu J, Lee SH, Kolattukudy PE, et al. (2002) A protease-activated pathway underlying Th cell type 2 activation and allergic lung disease. J Immunol 169: 5904-5911.
59. Lee SH, Kiss A, Xu J, Qian Y, Bashoura L, et al. (2004) Airway glycoprotein secretion parallels production and predicts airway obstruction in pulmonary allergy. J Allergy Clin Immunol 113: 72-78.
60. Angkasekwinai P, Chang SH, Thapa M, Watarai H, Dong C, (2010) Regulation of IL-9 expression by IL-25 signaling. Nat Immunol 11: 250-256.
61. Angkasekwinai P, Park H, Wang YH, Chang SH, Corry DB, et al. (2007) Interleukin 25 promotes the initiation of proallergic type 2 responses. J Exp Med 204: 1509-1517.
62. Kildsgaard J, Hollmann TJ, Matthews KW, Bian K, Murad F, et al. (2000) Cutting edge: targeted disruption of the C3a receptor gene demonstrates a novel protective anti-inflammatory role for C3a in endotoxin-shock. J Immunol 165: 5406-5409.
63. Chung Y, Lee SH, Kim DH, Kang CY, (2005) Complementary role of CD4+CD25+ regulatory T cells and TGF-beta in oral tolerance. J Leukoc Biol 77: 906-913.
64. Chung Y, Nurieva R, Esashi E, Wang YH, Zhou D, et al. (2008) A critical role of costimulation during intrathymic development of invariant NK T cells. J Immunol 180: 2276-2283.
65. Chung Y, Cho J, Chang YS, Cho SH, Kang CY, (2002) Preventive and therapeutic effects of oral tolerance in a murine model of asthma. Immunobiology 206: 408-423.
66. Sheerin NS, Risley P, Abe K, Tang Z, Wong W, et al. (2008) Synthesis of complement protein C3 in the kidney is an important mediator of local tissue injury. FASEB J 22: 1065-1072.
67. Dillard P, Wetsel RA, Drouin SM, (2007) Complement C3a regulates Muc5ac expression by airway Clara cells independently of Th2 responses. Am J Respir Crit Care Med 175: 1250-1258.
68. Monsinjon T, Gasque P, Ischenko A, Fontaine M, (2001) C3A binds to the seven transmembrane anaphylatoxin receptor expressed by epithelial cells and triggers the production of IL-8. FEBS Lett 487: 339-346.
69. Dunkelberger JR, Song WC, (2010) Role and mechanism of action of complement in regulating T cell immunity. Mol Immunol 47: 2176-2186.
70. Chen Y, Haines CJ, Gutcher I, Hochweller K, Blumenschein WM, et al. (2011) Foxp3(+) regulatory T cells promote T helper 17 cell development in vivo through regulation of interleukin-2. Immunity 34: 409-421.
71. Weaver CT, Harrington LE, Mangan PR, Gavrieli M, Murphy KM, (2006) Th17: an effector CD4 T cell lineage with regulatory T cell ties. Immunity 24: 677-688.
72. Kiss A, Montes M, Susarla S, Jaensson EA, Drouin SM, et al. (2007) A new mechanism regulating the initiation of allergic airway inflammation. J Allergy Clin Immunol 120: 334-342.
73. Mizutani N, Nabe T, Yoshino S, (2009) Complement C3a regulates late asthmatic response and airway hyperresponsiveness in mice. Journal of immunology 183: 4039-4046.
74. Wang YH, Voo KS, Liu B, Chen CY, Uygungil B, et al. (2010) A novel subset of CD4(+) T(H)2 memory/effector cells that produce inflammatory IL-17 cytokine and promote the exacerbation of chronic allergic asthma. J Exp Med 207: 2479-2491.
75. Fang C, Zhang X, Miwa T, Song WC, (2009) Complement promotes the development of inflammatory T-helper 17 cells through synergistic interaction with Toll-like receptor signaling and interleukin-6 production. Blood 114: 1005-1015.
76. Guo RF, Ward PA, (2005) Role of C5a in inflammatory responses. Annu Rev Immunol 23: 821-852.
77. Hashimoto M, Hirota K, Yoshitomi H, Maeda S, Teradaira S, et al. (2010) Complement drives Th17 cell differentiation and triggers autoimmune arthritis. J Exp Med 207: 1135-1143.
78. Weaver DJ Jr, Reis ES, Pandey MK, Kohl G, Harris N, et al. (2010) C5a receptor-deficient dendritic cells promote induction of Treg and Th17 cells. Eur J Immunol 40: 710-721.
79. Bosmann M, Sarma JV, Atefi G, Zetoune FS, Ward PA, (2012) Evidence for anti-inflammatory effects of C5a on the innate IL-17A/IL-23 axis. FASEB journal: official publication of the Federation of American Societies for Experimental Biology 26: 1640-1651.
80. Valdez PA, Vithayathil PJ, Janelsins BM, Shaffer AL, Williamson PR, et al. (2012) Prostaglandin E2 suppresses antifungal immunity by inhibiting interferon regulatory factor 4 function and interleukin-17 expression in T cells. Immunity 36: 668-679.
81. Hartung HP, Bitter-Suermann D, Hadding U, (1983) Induction of thromboxane release from macrophages by anaphylatoxic peptide C3a of complement and synthetic hexapeptide C3a 72-77. J Immunol 130: 1345-1349.
82. Hansch GM, Seitz M, Martinotti G, Betz M, Rauterberg EW, et al. (1984) Macrophages release arachidonic acid, prostaglandin E2, and thromboxane in response to late complement components. J Immunol 133: 2145-2150.
83. Veldhoen M, Hocking RJ, Atkins CJ, Locksley RM, Stockinger B, (2006) TGFbeta in the context of an inflammatory cytokine milieu supports de novo differentiation of IL-17-producing T cells. Immunity 24: 179-189.